Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors
University of California, San Francisco
University of California, San Francisco
Genentech, Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Bristol-Myers Squibb
Nammi Therapeutics Inc
Jazz Pharmaceuticals
EMD Serono
National Cancer Institute (NCI)
SystImmune Inc.